Franklin Street Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
2016
Q4
$121K Hold
2016
Q3
$146K Hold
2016
Q2
$110K Hold
2016
Q1
$108K Buy
2015
Q4
$90K Buy
2015
Q3
$41K Buy